About this document

Vaccines 11 01599 by ashaymane18 is a document available to read on EtoBox.

This review discusses recent advancements in mRNA-based cancer vaccines, highlighting their mechanisms of action, neoantigen discovery, and clinical trial progress. It emphasizes the potential of mRNA technology, especially following its success in COVID-19 vaccines, to revitalize cancer immunotherapy. The document also outlines challenges in identifying suitable neoantigens and the importance of targeting shared antigens for effective vaccine development.

Author

ashaymane18

Language

EN